Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Prolonged RBC Storage before Transfusion Increases Extravascular Hemolysis

By LabMedica International staff writers
Posted on 02 Feb 2017
Red blood cell transfusion, the most common procedure performed on hospitalized patients, is an indispensable component of modern medicine and establishing an adequate blood supply depends on the ability to store donated red cells safely.

Some countries have limited the maximum allowable storage duration for red cells to five weeks before transfusion, while in the USA, red blood cells can be stored for up to six weeks, but randomized trials have not assessed the effects of this final week of storage on clinical outcomes.

Scientists at the Columbia University Medical Center and their colleagues randomly assigned a group of 60 healthy volunteers to receive a unit of red blood cells that had been stored for 1, 2, 3, 4, 5, or 6 weeks. More...
The volunteers were then monitored for 20 hours after transfusion. Chromium-51 (51Cr) post transfusion red cell recovery studies were performed and laboratory parameters measured before and at defined times after transfusion.

Routine laboratory parameters were measured and transferrin saturation and total iron binding capacity were calculated from the measured serum iron and unbound iron-binding capacity. Nontransferrin-bound iron was measured using an ultrafiltration assay and this method correlated well with other techniques. Plasma-free hemoglobin was measured by a modified cyanomethemoglobin method. Commercial enzyme-linked immunosorbent assay (ELISA) kits were used to measure Hepcidin and interleukin -6.

The authors found that extravascular hemolysis after transfusion progressively increased with increasing storage time. Longer storage duration was associated with decreasing post-transfusion red cell recovery, decreasing elevations in hematocrit, and increasing serum ferritin. After six weeks of refrigerated storage, transfusion was followed by increases in area under the curve (AUC) for serum iron, transferrin saturation, and nontransferrin-bound iron as compared with transfusion after one to five weeks of storage. Within hours after transfusion, seven of the nine volunteers who received the 6-week-old blood could not appropriately metabolize the damaged cells, thereby releasing large amounts of iron into their bloodstream.

Eldad A. Hod, MD. Assistant Professor of Pathology and senior author of the study said, “Based on the amount of iron circulating in the blood of the volunteers who received six-week-old blood, we'd predict that certain existing infections could be exacerbated. It's estimated that up to 10% to 20% of blood units used for transfusions have been stored for more than five weeks, so the number of patients who are likely to receive a unit of very old blood is substantial.” The study was published in the January 2017 issue of the Journal of Clinical Investigation.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.